Objective and design The aim of this study is to evaluate the expression of the histamine receptors, particularly focusing on the H 4 R in human renal tubules. Material The ex vivo evaluation was carried on specimens from human renal cortex. Primary and immortalized tubular epithelial cells (TECs) and the HK-2 cell line were used as in vitro models. Treatment Cells were pretreated for 10 min with chlorpheniramine maleate 10 lM (H 1 R antagonist), ranitidine 10 lM (H 2 R antagonist), GSK189254 1 lM (H 3 R antagonist) or JNJ7777120 10 lM (H 4 R antagonist), and then exposed to histamine (3 pM-10 nM) for 30 min.
Introduction
Histamine is a pleiotropic amine ubiquitously distributed, that exerts its effects through four subtypes of G-proteincoupled receptors, namely H 1 receptor (H 1 R), H 2 receptor (H 2 R), H 3 receptor (H 3 R) and H 4 receptor (H 4 R), differentially expressed in various tissues and cell types. The presence of histamine in the kidney has been detected for decades. It can derive from resident mast cells [1] , glomerular cells, which have been reported as a major site of intrarenal histamine synthesis and accumulation [2] , and from proximal tubular epithelial cells, where the expression of the enzyme histidine decarboxylase (HDC) has been demonstrated [3] .
Indirect evidence sustains the hypothesis that histamine could be involved in renal physiology in humans. In healthy subjects, the administration of loading doses of Lhistidine led to an increase of histamine concentration in urine, but not in blood [4] . In renal transplant patients, the urinary and blood levels of histamine are elevated [5] . Moreover, some evidence suggests that histamine may be involved in diabetes-related kidney disease. Indeed, in the kidney of diabetic rats, histamine was increased compared with controls [6, 7] . Independent studies indicate that histamine regulates the renal microcirculation, by increasing salt and water excretion [8] [9] [10] , decreasing the ultrafiltration coefficient by reducing the total filtration surface area [10] , and increasing renin release [11] .
The renal effects of histamine have been first ascribed only to H 1 R and H 2 R, both identified in the glomeruli [12, 13] . Recently, a possible role for H 4 R has been suggested by our research group [14] . While a very low mRNA level of the latest discovered histamine receptor has been reported in the kidney of dog, monkey, rat, mouse, guinea pig and pig [15] [16] [17] [18] [19] [20] , in 2013 we demonstrated the presence of H 4 R in resident renal cells of the loop of Henlé and its profound upregulation in the kidney of diabetic rats [14] . Notably, these data provide the first basis to hypothesize a possible involvement of H 4 R in the onset/progression of diabetes-associated renal disease. However, this study, as well as the majority of the previous research, was conducted on rodents and the demonstration of the presence of the histamine receptors in the human kidney is still lacking. Thus, herein we aimed to extend our previous observation on renal H 4 R from rats to humans. The study herein was focused on the renal tubules and the H 4 R was evaluated in different cells, using both the immortalized human proximal tubular epithelial cell line human kidney 2 (HK-2), and human tubular epithelial cells (TECs). Moreover, herein, we broadened our investigation to all of the four histamine receptors.
Materials and methods

Reagents
All reagents and chemicals used were from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. GSK189254 (PubMed CID 24768876) was kindly supplied by Prof. E. Masini, University of Florence, Italy. Cell media and cell reagents were from Lonza group Ltd. (Allendale, NJ, USA). Hanks' balanced salt solution was from GIBCO (Grand Island, NY Histamine dihydrochloride (PubMed CID 5818), chlorpheniramine maleate (PubMed CID 5281068), ranitidine hydrochloride (PubMed CID 3033332), GSK189254 and JNJ7777120 (PubMed CID 4908365) were dissolved in dimethyl sulfoxide, and the final drug concentrations were obtained by dilution of stock solutions in the experimental buffers. The final concentration of the organic solvent was \0.1 %, which had no effect on cell viability. Antibodies H 3 R and H 4 R were detected using the anti-hH 3 R (349-358) and the anti-hH 4 R (374-390) antibodies produced and validated for detecting both human and rodent H 3 R and H 4 R in the School of Biological and Biomedical Sciences, Durham University [21] [22] [23] [24] [25] [26] [27] . In brief, anti-hH 3 R antibody was generated coupling the peptide corresponding to the amino acids RLSRDRKVAK Cys of the human and rat H 3 R to thyroglobulin by m-maleimidobenzoic acid N-hydroxysuccinimide ester coupling method as described previously [6] and antibodies were raised in rabbits to the resultant conjugate. Anti-peptide antibody production was monitored by enzyme-linked immunosorbent assay with the peptide H 3 (349-358) as the antigen. The anti-hH 4 R antibody was generated against the last 17 amino acids of the C-terminal tail of the H 4 R conjugating the peptide corresponding to the amino acids CIKKQPLPSQHSRSVSS to thyroglobulin by the cysteine-coupling method [28] . The resultant conjugate was used to generate polyclonal antibodies in rabbits. The selectivity of the anti-hH 4 R antibody was confirmed by blockade with the C-terminal peptide of the H 4 R and a lack of cross-reactivity with the human H 3 R, the most closely related G-protein-coupled receptors [21] . The antibodies for histamine H 1 R (H300, sc-20633) and H 2 R (A20, sc-19773) were purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA).
Immunohistochemistry
Conventional immunohistochemical procedures were employed as described previously [14, 29, 30] . In brief, immunoperoxidase staining for H 1 R, H 2 R, H 3 R and H 4 R was performed on 5 lm sections for formalin-fixed tissue from 12 patients who underwent elective nephrectomy as first-line therapy for renal carcinoma at the Urology Surgery of the A.O.U. Città della salute e della Scienza of Turin, Italy, after approval of the Ethical Committee for the use of human tissue of the Department of Medical Sciences of the University of Turin, Italy. Incubation with sodium citrate 50 mM pH 8.4 for 30 min at room temperature followed by sodium citrate 50 mM pH 8.4 for 30 min at 80°C was performed for antigen retrieval. Sections were incubated overnight with anti-H 1 R (1.3 lg/ml), anti-H 2 R (1.3 lg/ml), anti-H 3 R (1 lg/ml) or anti-H 4 R (2 lg/ml) receptor subunit at 4°C, followed by a three-layer streptavidin-biotin-peroxidase complex staining method (Vectastain ABC Elite kit and 3 0 ,3-diaminobenzidine tetrahydrochloride, DAB; Vector Laboratories, Inc.). Tissue was also screened in the absence of primary antibody, where in all cases, a major part of the staining was abolished (data not shown). All sections were stained or immunostained in a single session to minimize artifactual differences in the staining. Photomicrographs of the histological slides were acquired randomly with a digital camera connected to a light microscope equipped with a 209 objective (Olympus BH2).
Cell cultures
In this study, the following cell types, primary (p) and immortalized (1) TECs from human renal cortex and HK-2 cell line, were used. Primary cultures were obtained from the normal portion of cortex surgically removed kidneys (n = 5) as described previously [31] . The healthy tissue was derived from kidney samples of patients who underwent unilateral nephrectomy due to renal carcinomas as first-line treatment. To our knowledge, no other relevant pathology was diagnosed in the medical history of each patient enrolled and no drugs able to induce histamine release were used in treatment. In brief, after dissection of the cortex and passage through a graded series of meshes, a mixed population of pTECs was plated in DMEM containing 1 mg/l glucose supplemented with 10 % FCS, penicillin/streptomycin (100 IU/ml), and L-glutamine and the cultures were maintained at 37°C in a 95 % air/5 % CO 2 humidified incubator. iTECs were obtained from the respective primary cells by infection with a hybrid Adeno5/ SV40 virus as previously described [31] [32] [33] [34] . These cells showed negative staining for von Willebrand factor, minimal staining for desmin, and marked staining with antibodies to cytokeratins, actin, and alkaline phosphatase [32] . Primary cultures were used within first three passages. HK-2, immortalized human proximal tubular epithelial cells from American Type Culture Collection (Number CRL-2190), were cultured in DMEM containing 1 mg/l glucose supplemented with 10 % FCS, penicillin/streptomycin (100 IU/ml), and L-glutamine and the cultures were maintained at 37°C in a 95 % air-5 % CO 2 humidified incubator.
RT-PCR
Two lg/ll of total RNA extracted from kidney epithelial cells was processed by RevertAid TM First Strand cDNA Synthesis Kit according to the manufacturer's instruction and subjected to RT-PCR as previously described [35] . In brief, RT-PCR amplifications were performed in 25 ll reaction mixtures containing 2 ll of cDNA, 2.5 ll of 109 buffer, 1.0 ll of 50 mM MgCl 2 , 0.20 ll of 25 mM dNTPs mix, 0.05 U of EuroTaq DNA polymerase, and 2.5 ll of 5 lM sequence-specific oligonucleotide primers reported in Table 1 . PCR amplicons were resolved in an ethidium bromide-stained agarose gel (2.5 %) by electrophoresis. GADPH gene expression was used as an internal control.
Immunocytofluorescence
Cells were fixed with 4 % paraformaldehyde in PBS and permeabilized with 0.1 % TritonX-100. Immunofluorescence was performed using the indicated antibodies against the histamine receptors, followed by incubation with Alexa-conjugated secondary antibodies (invitrogen). Nuclei were stained with Hoechst (Sigma). All the slides were examined at 409 magnification using Apotome systems (Zeiss).
Time-resolved fluorescence resonance energy transfer (TR-FRET)
The TR-FRET assay was used to evaluate cellular cAMP and IP 1 production using the LANCE Ò Ultra cAMP Detection Kit and the IP-One HTRF Ò assay kit, respectively, according to the manufacturer's instruction. In brief, for cAMP, 10,000 cells/well, pretreated with vehicle alone or with ranitidine 1 lM or 10 lM (H 2 R antagonist), GSK189254 0.1 or 1 lM (H 3 R antagonist) or JNJ7777120 1 or 10 lM (H 4 R antagonist) for 10 min, were exposed to histamine in the range 3 pM-10 nM for 30 min in presence of IBMX 0.5 mM. After 1 h incubation at room temperature with Eu 3? -labeled antibody and allophycocyanin-labeled antibody, energy transfer was measured by exciting the Eu 3? at 320 nm and monitoring the allophycocyanin emission at 665 nm using the multiple plate reader Victor X (PerkinElmer Inc.). Data were expressed as TR-FRET signal over the basal one.
Similarly, for IP1, the downstream stable metabolite of IP3, 50,000 cells/well were pretreated with vehicle alone or chlorpheniramine maleate 1 or 10 lM (H 1 R antagonist) for 10 min and exposed to histamine in the range 3 pM-300 nM for 1 h. After incubation for 1 h at room temperature with IP-One Tb conjugate and Lumi4
TM -Tb criptate-labeled antibody, energy transfer was measured by exciting the Lumi4 TM -Tb criptate at 320 nm and monitoring the emission at both 620 and 665 nm using the multiple plate reader Victor X. Results are expressed as the 665/620 nm ratio over the basal one.
Statistical analysis
In some cases (Figs. 3, 5 ), data were best-fitted as sigmoid concentration-response curves, and analyzed with a fourparameter logistic equation using the software Origin version 6.0 (Microcal Software, Northampton, MA). Results are shown as mean ± SEM and were analyzed by Student's t test or one-way ANOVA with Dunnett's multiple comparison to determine significant differences between mean values: P values \ 0.05 were considered significant. Data analysis was performed testing for normality using the Kolmogorov-Smirnov test by Prism 4 software from Graphpad (CA, USA).
Results
Histamine receptor identification in the human renal tubules
To evaluate the expression of the four histamine receptors, 12 human renal cortex specimens were subjected to immunohistochemical analysis. As shown in Fig. 1,  immunolabeling for each of the antibodies tested was detected in the tubules, thus suggesting that all four receptor subtypes are present. In particular, specific H 1 R, H 2 R and H 4 R immunoreactivities were found at the tubular level, with a robust positivity for H 4 R at the basal membrane of some tubular epithelial cells. Most intriguingly, immunolabeling sections with the anti-H 3 R antibody yielded staining only on some tubule epithelium, with a stronger signal at the apical membrane. No staining was detected with specimens probed in the absence of primary antibodies (not shown).
Histamine receptor expression in human renal cells
The expression of the four histamine receptors was evaluated at both gene (Fig. 2a) and protein (Fig. 2b ) levels in different human tubular epithelial cells (HK-2, iTECs and pTECs). As shown in Fig. 2a , single transcripts corresponding to the size predicted for H1R (403 bp), H2R (497 bp), H3R (221 bp) and H4R (353 bp) were obtained in both pTECs and iTECs. Consistently, both the cell cultures showed positive staining for all four receptors when the protein expression was evaluated by immunofluorescence (Fig. 2b) . These results indicate that all the histamine receptor subtypes are expressed in these cells. Given the similarity between primary and immortalized cells, we used the immortalized cells for the next set of experiments. In comparison to all TECs tested, only the single transcripts corresponding to the size predicted for H1R and H4R were observed in HK-2, while the transcript corresponding to the size predicted for H2R was undetectable. H 3 R protein was confined to some cells from tubules, but no transcript for H3R was detected on the HK-2 cell line (Fig. 2a) . These results were confirmed when histamine receptors were analyzed by immunofluorescence. Indeed, as shown in Fig. 2b , H 1 R showed a diffuse staining in all the cells tested, with a predominant localization in the membrane of some HK-2 cells and in the perinuclear zone in iTECs. In comparison, when H 4 R was considered, diffuse staining was observed with a prevalent signal at the cytoplasmic level; however, a membrane localization of H 4 R signal was also found in some iTECs. A similar result was obtained for H 2 R: detected in the cytoplasm; it was also clearly visible on the membrane in iTECs. Finally, H 3 R was only expressed by iTECs. Similarly to iTECs, pTECs expressed all the four histamine receptor subtypes.
Second messenger production evoked by histamine in human renal cells
To confirm the functional expression of the histamine receptors suggested by RT-PCR and antibody labeling, we tested the activation of the histamine receptors evaluating the production of second messengers in iTECs, and HK-2 cell line challenged with histamine utilizing a TR-FRET assay.
To evaluate the effect of histamine on the activation of the H 1 R, a G q -protein-coupled receptor, the levels of IP 1 , the downstream more stable metabolite of IP 3 , were measured. Cells exposed for 1 h to histamine 3 pM-300 nM showed a concentration-dependent decrease in TR-FRET signal (Fig. 3) , which indicates an increase of IP 1 . Notably, a concentration-dependent relationship was reported for both the cell types. Different EC 50 s for histamine were observed: 0.56 ± 0.04 nM for HK-2 ( Fig. 3a) and 8.84 ± 0.89 nM for iTECs (Fig. 3b) . The pretreatment for 10 min with the selective H 1 R antagonist chlorpheniramine maleate at either 1 or 10 lM shifted in a concentrationdependent manner the curves evoked by histamine, thus confirming the functional expression of H 1 R in the renal cells. However, differences between the two cell lines were still observed, with chlorpheniramine maleate exerting a surmountable antagonism in HK-2 cells (Fig. 3a) and an apparent non-competitive antagonism in iTECs (Fig. 3b) .
To evaluate the effect of histamine on the activation of the G s protein, preferentially coupled with H 2 R, and G i protein, coupled with both H 3 R and H 4 R, protein, the levels of cAMP were measured. As shown in Fig. 4 , iTECs exposed for 30 min to histamine 3 pM-10 nM produced a double bell-shaped dose-response curve: the first in the 3 pM-0.1 nM range, with the maximum increase in TR-FRET signal at 0.02 nM, the second in the 0.1-10 nM range, with the maximum increase achieved at 0.4 nM (Fig. 4a) . When singly administered, ranitidine 1 or 10 lM modified both the two peaks of cAMP production at 0.1 and 10 nM, respectively (Fig. 4b) , GSK189254 0.1 or 1 lM suppressed the second bell-shaped curve (Fig. 4c) , while JNJ7777120 (1 or 10 lM) ablated the first highaffinity histamine response (Fig. 4d) . Notably, the co-administration of all three antagonists completely abolished the effect evoked by histamine (Fig. 4e) . Thus, the data herein obtained are consistent with the presence of H 2 R, H 3 R and H 4 R. In comparison to iTECs, the HK-2 cell line (Fig. 5 ) displayed a single sigmoid increase in TR-FRET signal (EC 50 1.04 ± 0.15 nM), suggesting that only a G iprotein-coupled receptor is expressed. The antagonism produced by JNJ7777120 10 lM indicates that the contributing receptor to this latter effect is the H 4 R.
Discussion
This study provides the first comparative evaluation of the four histamine receptor expression in the human renal tubules. Whether functional histamine receptors are expressed by human renal cells has been scantly investigated, with studies identifying H 1 R and H 2 R based on the use of pharmacological tools [32, 33] . Herein, using combined molecular, anatomical and pharmacological strategies, we provide convergent lines of evidence strongly supporting the conclusions that all histamine receptors are present in the kidney. In particular, our study was focused on tubules, where we demonstrate that all of the histamine receptors are expressed on epithelial cells.
Our in vitro observations were performed on two epithelial tubular cell lines iTECs and HK-2. iTECs were Ò assay kit (Cisbio) in HK-2 (a) and iTECs (b) 50,000 cells/ well pretreated for 10 min with vehicle alone (black square, solid line) or the selective H 1 R antagonist, chlorpheniramine maleate 1 lM (black circle, dash-dot line) or 10 lM (white circle, dash line), were exposed to histamine (3 pM-300 nM) for 1 h. Results, calculated from the 665/620 nm ratio, are expressed as increase over the basal and are the mean ± SEM of three independent experiments run in duplicate. Statistical analysis was performed by one-way ANOVA and Dunnett's test c Fig. 4 cAMP production in tubular epithelial cells. cAMP was measured, according to the manufacturer's instruction, by LANCE Ultra cAMP assay (PerkinElmer) in iTECs: 10,000 cells/well, pretreated for 10 min with vehicle alone (a) or the selective H 2 R antagonist, ranitidine 1 lM (black turbot) or 10 lM (white turbot) (b) the selective H 3 R antagonist, GSK189254 0, 1 lM (black triangle) or 1 lM (white triangle) (c) or the selective H 4 R antagonist, JNJ7777120 1 lM (black star) or 10 lM (white star) (d) alone, or coadministrated (e) were exposed to histamine (3 pM-10 nM) for 30 min. Results, expressed as TR-FRET signal at 665 nm over the basal, are the mean ± SEM of three independent experiments run in duplicate. Statistical analysis was performed by one-way ANOVA and Dunnett's test. *P \ 0.05; **P \ 0.01; ***P \ 0.001 vs. 0 and # P \ 0.05; ## P \ 0.01 vs. higher dose isolated from human renal cortex and represent a mixed population of tubular epithelial cells, while HK-2 is a commercially available pure proximal tubular epithelial cell line, selected for study based on the assumption that the most abundant epithelial tubular cells within the cortex are proximally located. Moreover, to avoid bias due to the cell immortalization process, we also compared primary cells pTECs to the corresponding immortalized human cells.
H 1 R, H 2 R and H 4 R were found in all the cell types tested, thus demonstrating an even distribution along the tubules; while H 3 R was confined to a minor subpopulation of renal cells as expressed only by TECs. These data extend the previous findings on the localization of H 1 R and H 2 R in mammalian glomeruli [2, 13, 36] to other nephron components, such as tubular epithelial cells. Moreover, we extended our recent observation on H 4 R expression in the kidney of rats [14] , now demonstrating its expression on human proximal tubular cells. Although we previously reported that in the kidney of rats the H 4 R is expressed by resident renal cells of the loop of Henlé, and not by proximal tubular cells as observed in humans, these two apparently contrasting observations are in keeping with the intra-species differences of H 4 R expression already widely reported [16] . Moreover, the present study was performed only on renal cortex-derived specimens and cells, thus a wider distribution also in the medulla and on the epithelial cells of the human loop of Henlé could not be ruled out.
An original and unexpected result of our study is the H 3 R identification on renal tubular epithelial cells. It has been largely demonstrated that H 3 R is mostly expressed in the central and, to a lesser extent, in the peripheral nervous system. Only a small number of experimental observations have showed its presence on non-neuronal cell types such as rodent fundic mucosa endocrine cells [26] , cholangiocytes [37] , pancreatic b-cells [38] , and in the human bronchial epithelial cell line BEAS-2B [39] . Therefore, our data add a new non-neuronal localization of the H 3 R, contributing to the hypothesis that the H 3 R could also mediate non-neuronal histamine effects. It is not sufficient to claim the presence of histamine receptors in the renal tubules based purely on PCR and immunological techniques, thus a pharmacological approach was adopted herein to provide stronger evidence for the presence of functional histamine receptors.
The canonical H 1 R-mediated response (second messenger IP 3 , evaluated by IP 1 ) was measured in both HK-2 and iTECs, consistent with the observed H 1 R mRNA and protein expression. The involvement of histamine-mediated cAMP response was also demonstrated in both of the cell types tested. In HK-2, although both H 2 R and H 4 R were identified at both the gene and protein level, histamine evoked only a reduction in cAMP, consistent with a G i -protein-coupled receptor such as H 4 R. Indeed, JNJ7777120 completely ablated the histamine-evoked effect in this cell line. This finding, in keeping with the apparent largely cytoplasmatic localization of H 2 R, suggests that in HK-2, this receptor is non-functional. Perhaps, the presence of nM histamine in the media (results not shown) has down-regulated this receptor.
The complex non-sigmoid shape of the concentrationresponse curve observed in iTECs for cAMP is likely a composite of the response evoked by histamine through H 2 R, H 3 R and H 4 R. Indeed, only the co-administration of ranitidine, GSK189254 and JNJ7777120 completely blunted the effect evoked by histamine in iTECs. The EC 50 s observed for H 1 R-mediated response ranged from 0.56 ± 0.04 nM for HK-2 to 8.84 ± 0.89 nM for iTECs. For H 4 R in HK-2 cell line, the EC 50 was 0.97 ± 0.02 nM; in iTECs the effect of histamine through H 4 R was displayed at picomolar concentrations. These differences in the EC 50 s between the two cell lines could be ascribed to the different intracellular localization of the histamine receptors: H 1 R and H 4 R displayed a predominant membrane localization in the HK-2 and iTECs, respectively. Notably, the values of EC 50 herein determined are lower than the Kd values reported for each receptor challenged by the natural ligand. It is known that H 1 R and H 2 R have an affinity in the micromolar range, whereas H 3 R and H 4 R are high-affinity [40] . The discrepancy between both the measured EC 50 s and the reported Kd values, and the discrepancies among the tested cell types could be explained by differences in receptor reserves [41] , species variance and/or the presence of isoforms, already reported for H 3 R and H 4 R [27] . It has been reported that the H 4 R splice variants are able to retain H 4 R 390 (the full length variant) intracellularly [27] . The possible presence of different dominant negative H 4 R variants is in keeping with the cytoplasmatic staining observed when cells were immunolabeled with the anti-full length H 4 R isoform antibody. Furthermore, the presence of nM histamine (results not shown) in the media may also increase the apparent potencies of histamine in these functional studies. The apparent non-competitive behavior displayed by chlorpheniramine maleate in iTECs, compared to the surmountable antagonism showed in HK-2, is in keeping with previous observations of a pronounced non-competitive antagonism of first-generation H 1 R antagonists in some cellular systems such as HL-60 and HeLa cells, and could be explained by non-equilibrium conditions, as already reported [42] .
In conclusion, our results provide the first dual anatomical and functional identification of the histamine receptor family in human kidney tubules. This new knowledge will foster a better understanding of the roles of histamine in renal pathophysiological conditions and may contribute to new therapeutic approaches.
